Molotkov, A.; Carberry, P.; Dolan, M.A.; Joseph, S.; Idumonyi, S.; Oya, S.; Castrillon, J.; Konofagou, E.E.; Doubrovin, M.; Lesser, G.J.;
et al. Real-Time Positron Emission Tomography Evaluation of Topotecan Brain Kinetics after Ultrasound-Mediated Blood–Brain Barrier Permeability. Pharmaceutics 2021, 13, 405.
https://doi.org/10.3390/pharmaceutics13030405
AMA Style
Molotkov A, Carberry P, Dolan MA, Joseph S, Idumonyi S, Oya S, Castrillon J, Konofagou EE, Doubrovin M, Lesser GJ,
et al. Real-Time Positron Emission Tomography Evaluation of Topotecan Brain Kinetics after Ultrasound-Mediated Blood–Brain Barrier Permeability. Pharmaceutics. 2021; 13(3):405.
https://doi.org/10.3390/pharmaceutics13030405
Chicago/Turabian Style
Molotkov, Andrei, Patrick Carberry, Martin A. Dolan, Simon Joseph, Sidney Idumonyi, Shunichi Oya, John Castrillon, Elisa E. Konofagou, Mikhail Doubrovin, Glenn J. Lesser,
and et al. 2021. "Real-Time Positron Emission Tomography Evaluation of Topotecan Brain Kinetics after Ultrasound-Mediated Blood–Brain Barrier Permeability" Pharmaceutics 13, no. 3: 405.
https://doi.org/10.3390/pharmaceutics13030405
APA Style
Molotkov, A., Carberry, P., Dolan, M. A., Joseph, S., Idumonyi, S., Oya, S., Castrillon, J., Konofagou, E. E., Doubrovin, M., Lesser, G. J., Zanderigo, F., & Mintz, A.
(2021). Real-Time Positron Emission Tomography Evaluation of Topotecan Brain Kinetics after Ultrasound-Mediated Blood–Brain Barrier Permeability. Pharmaceutics, 13(3), 405.
https://doi.org/10.3390/pharmaceutics13030405
